Ticker: AUPH

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) has released its financial results for the quarter ended June 30, 2025, and continues to experience both positive and negative trends in its operations. Positive Aspects: Revenue Growth: Total revenue increased 22.5% to $70 million for Q2 2025 compared...